OMAHA, Neb.–A clinical trial is underway pertaining to multiple sclerosis that could be changing the lives of those who receive the diagnosis.
49-year-old Jan Janisch-Hanzlik was recently diagnosed with MS that spread rapidly throughout her body.
Janisch-Hanzlik was referred to a neurologist and MS specialist at Nebraska Medicine who presented her with a new option for treatment: enrollment in a first-of-its-kind clinical trial using allogeneic CAR T-cell therapy…